Dec 9 (Reuters) - Krystal Biotech Inc KRYS.O:
KRYSTAL BIOTECH PROVIDES UPDATE ON EMA’S ONGOING REGULATORY REVIEW OF B-VEC FOR DYSTROPHIC EPIDERMOLYSIS BULLOSA
KRYSTAL BIOTECH INC: CHMP OPINION NOW EXPECTED IN 1Q 2025
KRYSTAL BIOTECH INC: NO MAJOR OBJECTIONS OUTSTANDING; CONTINUE TO EXPECT GERMANY LAUNCH IN 2Q 2025
Source text: ID:nGNX63yTqH
Further company coverage: KRYS.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.